FDA approves once-a-day pill for common skin cancer

Stephen FellerSILVER SPRING, Md., July 24 (UPI) -- The FDA announced that it approved the once-a-day pill Odomzo for patients with recurrent basal cell carcinoma or who can't have surgery or radiation therapy.

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Stephen FellerSILVER SPRING [+]    July 24 [+]    UPI [+]    FDA [+]    Odomzo [+]   

More #news: